Chimeric antigen receptor (CAR) T-cells on the march: from diffuse large B-cell lymphoma to mantle cell lymphoma

Eur J Cancer. 2020 May:131:51-52. doi: 10.1016/j.ejca.2020.03.001. Epub 2020 Apr 10.

Authors

Roch Houot¹, Philippe Armand², Caron A Jacobson²

Affiliations

¹ Department of Hematology, CHU de Rennes, Université de Rennes, INSERM U1236, EFS, Rennes, France; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. Electronic address: roch.houot@chu-rennes.fr.
² Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.

PMID: 32283478
DOI: 10.1016/j.ejca.2020.03.001

No abstract available

Publication types

Editorial
Comment

MeSH terms

Adult
Humans
Immunotherapy, Adoptive
Lymphoma, Large B-Cell, Diffuse*
Lymphoma, Mantle-Cell*
Receptors, Chimeric Antigen
T-Lymphocytes

Substances

Receptors, Chimeric Antigen